Fact.MR has released its latest report on the Tuberculosis Biomarkers Market, providing comprehensive insights into the global market’s steady growth, fueled by increasing research and development (R&D) efforts and the rising prevalence of tuberculosis (TB). The market is projected to expand at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2031, driven by advancements in diagnostic technologies and the growing demand for precise, rapid TB detection. This growth underscores the critical role of tuberculosis biomarkers in improving disease characterization, risk assessment, and treatment outcomes worldwide. https://www.factmr.com/report/569/tuberculosis-biomarkers-market